Catheter Precision, Inc. (VTAK) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Catheter Precision, Inc., a Delaware corporation, on October 30, 2024, covering events that occurred on October 29, 2024. The Company is incorporated in Delaware and maintains its principal executive offices in Fort Mill, South Carolina. Its common stock trades on the NYSE American under the symbol "VTAK."
Key Financial Metrics
The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The only financial data disclosed relates to a specific transaction:
- Transaction Consideration: $23.50 paid for the exercise of pre-funded warrants.
- Shares Acquired: 235,000 shares of common stock.
- Resulting Ownership: The Jenkins Family Charitable Institute's beneficial ownership increased to 6.32%.
Material Changes
The primary material change reported is the entry into a Waiver Agreement with the Jenkins Family Charitable Institute. Prior to this agreement, the Institute was restricted from fully exercising its pre-funded warrants due to a beneficial ownership limitation capping ownership at 9.99%. Following the waiver, the Institute exercised the warrants in full. This transaction was approved in advance by the Company's Board Audit Committee.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on future operations, or discussion of general business risks. The document focuses exclusively on the specific corporate action regarding the waiver of the beneficial ownership limitation. No unusual items or contingencies were disclosed outside of this transaction.
Key Facts for Investor Verification
- Verify the impact of the 235,000 new shares on total outstanding share count and potential dilution.
- Confirm the relationship between the Jenkins Family Charitable Institute and the Company's Chairman/CEO, David Jenkins, as disclosed in the filing.
- Review the attached Waiver Agreement (Exhibit 10.1) for any additional covenants or conditions not summarized in the text.
- Note that this filing does not contain updated financial statements or operational results.